Triglyceride-glucose index as a predictor of cardiovascular multimorbidity: a prospective cohort study
Frontiers in Cardiovascular Medicine · 14.11.2025 · 12
DOI: 10.3389/fcvm.2025.1647444 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 14.11.2025. Verfasst von Yushi Bao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Labortatory, Shanghai Songjiang District Sijing Hospital, Shanghai, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The triglyceride-glucose (TyG) index is a recognized marker of insulin resistance, yet its role in the dynamic progression from cardiovascular disease (CVD) to cardiovascular multimorbidity (CVM) remains unclear. This study aimed to evaluate the association between the TyG index and transitions from a CVD-free state to first CVD and subsequently to CVM.
Methods
In this prospective cohort study, we included participants from the Shanghai Suburban Adult Cohort who were free of CVD at baseline (2016). The TyG index was measured at baseline. Disease transitions were tracked over a median follow-up of 6.26 years. First CVD event was defined as the initial occurrence of coronary heart disease (CHD), stroke, or heart failure (HF), and CVM was defined as the presence of two or more of these conditions. Multi-state models were used to assess the association between the TyG index and transitions across health states, including disease-specific pathways.
Results
During a median follow-up of 6.26 years, 1,182 (3.79%) participants developed first CVD event, 671 (2.15%) developed CVM. TyG index played crucial but different roles in all transitions from healthy to first CVD event, to CVM (HR = 1.162, 95% CI: 1.074, 1.257; HR = 1.148, 95% CI: 1.010, 1.305). When we further divided first CVD events into CHD, Stroke, and HF, we found that TyG index played different roles in disease-specific transitions even within the same transition stage (HR = 1.145, 95% CI: 1.029, 1.273; HR = 1.228, 95% CI: 1.085, 1.391; HR = 1.213, 95% CI: 1.057, 1.391).
Conclusions
The TyG index is an independent predictor of dynamic progression toward cardiovascular multimorbidity, showing significant associations with atherosclerosis-driven conditions such as CHD and stroke but not with heart failure. These findings support its potential utility in risk stratification and preventive strategies across the cardiovascular disease continuum.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Labortatory, Shanghai Songjiang District Sijing Hospital, Shanghai, China.
- Department of Preventive Medicine and Health Education, School of Public Health, Fudan University, Shanghai, China.
- Department of Preventive Health Care, Zhongshan Community Health Care Center, Shanghai, China.
- Songjiang District Center for Disease Control and Prevention, Songjiang District Health Inspecting Agency, Shanghai, China.
Zitieren
APA
Bao, Y., Chen, H., Zhu, B., Tang, M., Wu, Q., Jia, Y., & Jiang, Y. (2025). Triglyceride-glucose index as a predictor of cardiovascular multimorbidity: a prospective cohort study. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1647444
Vancouver
Bao Y, Chen H, Zhu B, Tang M, Wu Q, Jia Y, et al. Triglyceride-glucose index as a predictor of cardiovascular multimorbidity: a prospective cohort study. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1647444
BibTeX
@article{Bao2025,
author = {Bao, Yushi and Chen, Hao and Zhu, Bolin and Tang, Minhua and Wu, Qiang and Jia, Yingnan and Jiang, Yonggen},
title = {Triglyceride-glucose index as a predictor of cardiovascular multimorbidity: a prospective cohort study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1647444}
}
EUVIMED